Clinical Drug Experience Knowledgebase

Acute Disease (Phase 1)

Adenocarcinoma (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 3)

Graft vs Host Disease (Phase 2)

Hematologic Diseases (Phase 2)

Inflammatory Breast Neoplasms (Phase 3)

Invasive Fungal Infections (Phase 2)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Myeloma (Phase 3)

Mycoses (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Pancreatic Neoplasms (Phase 3)

Plasmacytoma (Phase 2)

Precancerous Conditions (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Preleukemia (Phase 2)

Prostatic Neoplasms (Phase 3)

Rectal Neoplasms (Phase 3)

Recurrence (Phase 3)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 2)

Urinary Bladder Neoplasms (Phase 2)